Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNA2 | P20248 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16377730 | 1.00 | CCNA2 (0.31) | CCNA2CDK2CCNA1MAPTCNR2 | |
| SCHEMBL16377820 | 0.90 | MAPT (0.32) | CCNA2CDK2CCNA1MAPT | |
| SCHEMBL22607652 | 0.89 | ROCK2 (0.32) | CCNA2CDK2CCNA1MAPT | |
| SCHEMBL19326993 | 0.87 | MAPT (0.34) | CCNA2CDK2CCNA1MAPT | |
| SCHEMBL16339698 | 0.86 | NR1H4 (0.31) | — | |
| SCHEMBL16339733 | 0.86 | CCNA2 (0.36) | CCNA2CDK2CCNA1 | |
| SCHEMBL16377782 | 0.86 | CCNA2 (0.33) | CCNA2CDK2CCNA1MAPT | |
| SCHEMBL29670696 | 0.86 | CCNA2 (0.36) | CCNA2CDK2CCNA1 | |
| SCHEMBL16377988 | 0.86 | IRAK1 (0.32) | CCNA2CDK2CCNA1MAPT | |
| SCHEMBL16377727 | 0.85 | MAPT (0.31) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11365199-B2 | Pyrazole compounds as modulators of FSHR and uses thereof | MERCK PATENT GMBH (DE) | 2022-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11365199-B2 | Pyrazole compounds as modulators of FSHR and uses thereof | FSHR, GNRHR, LHCGR | CCNA2 4041/4885CDK2 602/4885CCNA1 3826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.